Literature DB >> 32354992

Cultured macrophages transfer surplus cholesterol into adjacent cells in the absence of serum or high-density lipoproteins.

Cuiwen He1, Haibo Jiang2, Wenxin Song1, Howard Riezman3,4, Peter Tontonoz5, Thomas A Weston1, Paul Guagliardo6, Paul H Kim1, Rachel Jung1, Patrick Heizer1, Loren G Fong7, Stephen G Young7,8.   

Abstract

Cholesterol-laden macrophage foam cells are a hallmark of atherosclerosis. For that reason, cholesterol metabolism in macrophages has attracted considerable scrutiny, particularly the mechanisms by which macrophages unload surplus cholesterol (a process referred to as "cholesterol efflux"). Many studies of cholesterol efflux in macrophages have focused on the role of ABC transporters in moving cholesterol onto high-density lipoproteins (HDLs), but other mechanisms for cholesterol efflux likely exist. We hypothesized that macrophages have the capacity to unload cholesterol directly onto adjacent cells. To test this hypothesis, we used methyl-β-cyclodextrin (MβCD) to load mouse peritoneal macrophages with [13C]cholesterol. We then plated the macrophages (in the absence of serum or HDL) onto smooth muscle cells (SMCs) that had been metabolically labeled with [15N]choline. After incubating the cells overnight in the absence of HDL or serum, we visualized 13C and 15N distribution by nanoscale secondary ion mass spectrometry (NanoSIMS). We observed substantial 13C enrichment in SMCs that were adjacent to [13C]cholesterol-loaded macrophages-including in cytosolic lipid droplets of SMCs. In follow-up studies, we depleted "accessible cholesterol" from the plasma membrane of [13C]cholesterol-loaded macrophages with MβCD before plating the macrophages onto the SMCs. After an overnight incubation, we again observed substantial 13C enrichment in the SMCs adjacent to macrophages. Thus, macrophages transfer cholesterol to adjacent cells in the absence of serum or HDL. We suspect that macrophages within tissues transfer cholesterol to adjacent cells, thereby contributing to the ability to unload surplus cholesterol.

Entities:  

Keywords:  cholesterol; macrophages; nanoSIMS imaging; smooth muscle cells

Mesh:

Substances:

Year:  2020        PMID: 32354992      PMCID: PMC7229689          DOI: 10.1073/pnas.1922879117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.

Authors:  M Bodzioch; E Orsó; J Klucken; T Langmann; A Böttcher; W Diederich; W Drobnik; S Barlage; C Büchler; M Porsch-Ozcürümez; W E Kaminski; H W Hahmann; K Oette; G Rothe; C Aslanidis; K J Lackner; G Schmitz
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

2.  A stable yeast strain efficiently producing cholesterol instead of ergosterol is functional for tryptophan uptake, but not weak organic acid resistance.

Authors:  Cleiton M Souza; Tatjana M E Schwabe; Harald Pichler; Birgit Ploier; Erich Leitner; Xue Li Guan; Markus R Wenk; Isabelle Riezman; Howard Riezman
Journal:  Metab Eng       Date:  2011-06-30       Impact factor: 9.783

3.  An efficient method for the production of isotopically enriched cholesterol for NMR.

Authors:  Rupali Shivapurkar; Cleiton M Souza; Damien Jeannerat; Howard Riezman
Journal:  J Lipid Res       Date:  2011-02-26       Impact factor: 5.922

4.  Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.

Authors:  Jenelle M Timmins; Ji-Young Lee; Elena Boudyguina; Kimberly D Kluckman; Liam R Brunham; Anny Mulya; Abraham K Gebre; Jonathan M Coutinho; Perry L Colvin; Thomas L Smith; Michael R Hayden; Nobuyo Maeda; John S Parks
Journal:  J Clin Invest       Date:  2005-04-07       Impact factor: 14.808

5.  Disrupting the LINC complex in smooth muscle cells reduces aortic disease in a mouse model of Hutchinson-Gilford progeria syndrome.

Authors:  Paul H Kim; Jennings Luu; Patrick Heizer; Yiping Tu; Thomas A Weston; Natalie Chen; Christopher Lim; Robert L Li; Po-Yu Lin; James C Y Dunn; Didier Hodzic; Stephen G Young; Loren G Fong
Journal:  Sci Transl Med       Date:  2018-09-26       Impact factor: 17.956

6.  ABCA1 contributes to macrophage deposition of extracellular cholesterol.

Authors:  Xueting Jin; Sebastian R Freeman; Boris Vaisman; Ying Liu; Janet Chang; Neta Varsano; Lia Addadi; Alan Remaley; Howard S Kruth
Journal:  J Lipid Res       Date:  2015-07-22       Impact factor: 5.922

7.  Three pools of plasma membrane cholesterol and their relation to cholesterol homeostasis.

Authors:  Akash Das; Michael S Brown; Donald D Anderson; Joseph L Goldstein; Arun Radhakrishnan
Journal:  Elife       Date:  2014-06-11       Impact factor: 8.140

8.  Continuous transport of a small fraction of plasma membrane cholesterol to endoplasmic reticulum regulates total cellular cholesterol.

Authors:  Rodney Elwood Infante; Arun Radhakrishnan
Journal:  Elife       Date:  2017-04-17       Impact factor: 8.140

9.  Release of cholesterol-rich particles from the macrophage plasma membrane during movement of filopodia and lamellipodia.

Authors:  Xuchen Hu; Thomas A Weston; Cuiwen He; Rachel S Jung; Patrick J Heizer; Brian D Young; Yiping Tu; Peter Tontonoz; James A Wohlschlegel; Haibo Jiang; Stephen G Young; Loren G Fong
Journal:  Elife       Date:  2019-09-05       Impact factor: 8.140

10.  ABCG1-mediated generation of extracellular cholesterol microdomains.

Authors:  Sebastian R Freeman; Xueting Jin; Joshua J Anzinger; Qing Xu; Sonya Purushothaman; Michael B Fessler; Lia Addadi; Howard S Kruth
Journal:  J Lipid Res       Date:  2013-11-08       Impact factor: 5.922

View more
  9 in total

Review 1.  Different Pathways of Cellular Cholesterol Efflux.

Authors:  Alexander D Dergunov; Veronika B Baserova
Journal:  Cell Biochem Biophys       Date:  2022-06-23       Impact factor: 2.989

Review 2.  Smooth Muscle Cell-Macrophage Interactions Leading to Foam Cell Formation in Atherosclerosis: Location, Location, Location.

Authors:  Pinhao Xiang; Valentin Blanchard; Gordon A Francis
Journal:  Front Physiol       Date:  2022-06-20       Impact factor: 4.755

Review 3.  Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis.

Authors:  Wei Chen; Maaike Schilperoort; Yihai Cao; Jinjun Shi; Ira Tabas; Wei Tao
Journal:  Nat Rev Cardiol       Date:  2021-11-10       Impact factor: 49.421

Review 4.  Lipid-Laden Macrophages and Inflammation in Atherosclerosis and Cancer: An Integrative View.

Authors:  Miriam Lee-Rueckert; Jani Lappalainen; Petri T Kovanen; Joan Carles Escola-Gil
Journal:  Front Cardiovasc Med       Date:  2022-02-14

Review 5.  Pathways and Mechanisms of Cellular Cholesterol Efflux-Insight From Imaging.

Authors:  Alice Dupont Juhl; Daniel Wüstner
Journal:  Front Cell Dev Biol       Date:  2022-03-01

6.  Maternal Hypercholesterolemia May Involve in Preterm Birth.

Authors:  Jingfei Chen; Lan Hua; Fei Luo; Jianlin Chen
Journal:  Front Cardiovasc Med       Date:  2022-07-11

Review 7.  Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis.

Authors:  Ping Ping Hu; Shuang Xue Luo; Xiao Qing Fan; Di Li; Xiao Yong Tong
Journal:  Front Pharmacol       Date:  2022-09-09       Impact factor: 5.988

8.  Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer.

Authors:  Asmaa El-Kenawi; William Dominguez-Viqueira; Min Liu; Shivanshu Awasthi; Julieta Abraham-Miranda; Aysenur Keske; KayLee K Steiner; Leenil Noel; Amparo N Serna; Jasreman Dhillon; Robert J Gillies; Xiaoqing Yu; John M Koomen; Kosj Yamoah; Robert A Gatenby; Brian Ruffell
Journal:  Cancer Res       Date:  2021-07-23       Impact factor: 12.701

9.  Cyclophilin A Impairs Efferocytosis and Accelerates Atherosclerosis by Overexpressing CD 47 and Down-Regulating Calreticulin.

Authors:  Vinitha Anandan; Thushara Thulaseedharan; Aishwarya Suresh Kumar; Karthika Chandran Latha; Amjesh Revikumar; Ajit Mullasari; Chandrasekharan C Kartha; Abdul Jaleel; Surya Ramachandran
Journal:  Cells       Date:  2021-12-20       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.